Preoperative immune prognostic index predicts the prognosis and postoperative adjuvant chemotherapy benefits of esophageal squamous cell carcinoma after minimally invasive esophagectomy
Preoperative IPI is a promising predictor of ESCC after MIE. For stage III ESCC patients with high IPI, AC can significantly reduce the risk of death or recurrence.
Authors
- Jin Huang (ORCID: https://orcid.org/0000-0002-8289-7071)
- Yunfan Luo (ORCID: https://orcid.org/0000-0001-5370-6777)
- Yan-Ming Shen
- Shuchen Chen (ORCID: https://orcid.org/0000-0002-3316-9908)
- Jie Chen (ORCID: https://orcid.org/0000-0002-8460-9088)
- Jihong Lin
- Chao Chen (ORCID: https://orcid.org/0000-0003-1028-3182)
- Shaojun Xu (ORCID: https://orcid.org/0000-0001-9996-0826)
- Z. T. Sun
Institutions
- Fujian Medical University (CN)
- Union Hospital (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2025-05-08
- DOI
- https://doi.org/10.1186/s12876-025-03959-z
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Fujian Medical University